Company page

Formycon Ag

Formycon AG is a publicly traded company based in Germany, with a market capitalization of approximately €383.79 million. The company focuses on the development of biosimilars and biopharmaceuticals, aiming to provide affordable treatment options in the healthcare sector. Formycon is committed to advancing its innovative product pipeline to meet the needs of patients and healthcare providers.